Amplefield Limited (SGX:AOF)

Ligand Pharmaceuticals Balance Sheet

Financials in millions SGD. Fiscal year is October - September.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Cash & Equivalents	1.51	2.15	0.82	0.87	0.47	0.81
Short-Term Investments	4.5	4.11	2.18	-	-	-
Cash & Short-Term Investments	6.01	6.26	3	0.87	0.47	0.81
Cash Growth	-23.32%	108.56%	245.57%	84.11%	-41.58%	5.90%
Accounts Receivable	1.22	1.9	5.16	5.16	5.87	5.29
Other Receivables	3.7	3.56	3.18	3.68	2.85	10.35
Receivables	4.92	5.46	8.35	8.84	8.72	15.64
Inventory	3.34	3.44	10.48	17.08	28	-
Restricted Cash	0.01	0.01	0.08	0.05	0.23	-
Other Current Assets	0.06	0.03	0	0	0	-
Total Current Assets	14.33	15.21	21.9	26.83	37.43	16.45
Property, Plant & Equipment	13.51	13.67	12.08	11.92	4.99	5.1
Long-Term Investments	1.97	1.97	3.65	3.68	3.56	3.68
Goodwill	0.12	0.12	0.11	0.12	1.28	1.23
Long-Term Accounts Receivable	9.75	9.71	9.61	9.44	9.41	-
Other Long-Term Assets	27.19	27.17	26.98	26.62	28.56	52.23
Total Assets	66.88	67.84	74.33	78.61	85.22	78.68
Accounts Payable	1.54	2.25	0.38	0.77	5.25	4.25
Accrued Expenses	1.6	1.51	1.9	1.68	2.77	2.08
Short-Term Debt	1.63	1.98	8.1	2.63	-	-
Current Portion of Long-Term Debt	-	-	-	6.66	3.61	0.57
Current Portion of Leases	0.76	0.76	0.02	0.02	0.03	0.03
Current Income Taxes Payable	-	0.05	0.04	0.04	0.05	0.07
Current Unearned Revenue	-	-	-	-	1.2	0.01
Other Current Liabilities	5.39	5.82	8.93	8.4	4.95	3.09
Total Current Liabilities	10.92	12.36	19.39	20.19	17.87	10.09
Long-Term Debt	-	0.11	0.11	0.11	0.19	0.21
Long-Term Leases	0.02	0.03	0.06	0.05	0.07	0.01
Long-Term Deferred Tax Liabilities	0.04	0.04	0.04	0.04	0.04	0.04
Other Long-Term Liabilities	0.2	0.31	0.16	0.16	0.07	0.24
Total Liabilities	11.18	12.86	19.76	20.55	18.24	10.6
Common Stock	68.21	68.21	68.21	68.21	68.21	68.21
Retained Earnings	-3.19	-3.61	-4.12	-2.43	2.92	2.52
Treasury Stock	-0.09	-0.09	-0.09	-0.09	-0.09	-0.09
Comprehensive Income & Other	-9.81	-9.93	-9.6	-7.76	-4.21	-2.69
Total Common Equity	55.12	54.58	54.4	57.93	66.84	67.95
Minority Interest	0.58	0.4	0.17	0.13	0.15	0.14
Shareholders' Equity	55.7	54.98	54.57	58.06	66.98	68.09
Total Liabilities & Equity	66.88	67.84	74.33	78.61	85.22	78.68
Total Debt	2.41	2.88	8.29	9.46	3.9	0.81
Net Cash (Debt)	3.6	3.38	-5.29	-8.59	-3.43	-0.01
Net Cash Per Share	0.00	0.00	-0.01	-0.01	-0.00	-0.00
Filing Date Shares Outstanding	898.12	898.12	898.12	898.12	898.12	898.12
Total Common Shares Outstanding	898.12	898.12	898.12	898.12	898.12	898.12
Working Capital	3.42	2.85	2.51	6.64	19.56	6.35
Book Value Per Share	0.06	0.06	0.06	0.06	0.07	0.08
Tangible Book Value	55	54.46	54.29	57.81	65.55	66.71
Tangible Book Value Per Share	0.06	0.06	0.06	0.06	0.07	0.07
Machinery	-	1.29	0.27	0.39	0.58	0.27

Source: S&P Global Market Intelligence. Standard template. Financial Sources.